Metabolic dysfunction plays a key role in the development of diabetic nephropathy (DN).
However, the exact effects and mechanisms are still unclear. The pyrin domain‐containing …

Low-grade chronic inflammation, also known as metabolic inflammation, promotes the
development of metabolic diseases. Increasing evidence suggests that changes in gut …

Previous studies found that exposure to polycyclic aromatic hydrocarbons (PAHs) was
associated with type 2 diabetes (T2D) prevalence. However, the potential mechanism is still …

The aim is to explore the treatment effect of coronary artery disease (CAD) and hypertension
on plasma levels of renalase activity and also the possible association of renalase …

Background Klotho, possibly an age-regulating protein, is considered an important factor
contributing to the lifespan and pathophysiology of hypertension and coronary artery …

Abstract Aims Interleukin-22 (IL-22) may be considered as an important cytokine in
maintenance and progression of hypertension and coronary artery disease (CAD). The aim …

Background CD36 is associated with regulation of lipid metabolism, atherosclerosis, and
blood pressure. Moreover, its variation may be involved in the development of hypertension …

The prevalence of metabolic diseases has become a severe public health problem.
Previously, we reported that Interleukin-22 (IL-22) was independently associated with type 2 …

This study was undertaken to assess the effects of glucagon-like peptide-1 receptor agonists
(GLP-1RAs), mainly liraglutide and exenatide, on glycemic control and anthropometric …

Purpose Both type 2 diabetes mellitus (T2DM) and hypertension are regarded as life-
threatening diseases known to be risk factors for vascular diseases. They may be associated …